GU Ke,ZHANG Jun-ning.Clinical assessment of radiotherapy for cancers with bone metastases[J].Chinese Journal of Radiological Medicine and Protection,2006,26(6):595-597
Clinical assessment of radiotherapy for cancers with bone metastases
Received:January 10, 2006  
DOI:
KeyWords:Carcinoma  Bone metastases  Radiotherapy
FundProject:
Author NameAffiliation
GU Ke Department of Radiotherapy, First Affiliated Hospital of Soochow University, Suzhou 215006, China
 
ZHANG Jun-ning Department of Radiotherapy, First Affiliated Hospital of Soochow University, Suzhou 215006, China
 
Hits: 2702
Download times: 1771
Abstract::
      Objective To estimate median survival time (MST) and assess pain-relief effect of radiotherapy for bone metastatic cancers. Methods During the period from July 1999 to June 2003, 79 cases of malignant tumors with 141 bone metastases were treated by 6 or 15 MV X-rays. Of the all cases, 18 cases were irradiated with conventional fraction: 20-25 times of irradiation during 4-5 weeks, 40-50 Gy in total; 61 cases were treated with lower fraction: 10-12 fractions during 2-2.5 weeks, 30-36 Gy in total. Results (1) Overall MST was estimated to be 3.81 months. MSTs of patients with bone metastases only and patients with both internal organ and bone matastases were 8.05 months and 3.10 months, respectively; the difference between the two kinds of patients was statistically significant (P<0.05). MSTs of those cases with primary lesion controlled and those cases with primary lesion uncontrolled or unspecified were 4.29 months and 3.31 months, respectively; the differences between them was statistically significant (P<0.05). However, the difference of MST between cases with single bone metastatic site and multiple bone metastatic sites was not significant (P>0.05). (2) The overall rate of pain-relief with radiotherapy was 92.90%, and not influenced by control of primary lesion, the number of bone metastatic sites, internal organ metastases, and dose fraction. (3) The relief of ostealgia occurred more promptly after irradiation with higher dose per fraction. Conclusions Radiotherapy could not only help to improve survival of bone metastatic carcinomas, but also be used as an effective and efficient treatment of ostealgia.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9076651  On-line:0

v
Scan QR Code
&et=3C06DB566315F8DC3A7544533942C5752DB888C3F6E6AC9619608E14DB82A321E713217DAA84DCB0C91091E0A994D82310886FFED666B966DDFFFC1E0A292BA3088036845BE3E2DA&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=37904DC365DD7266&aid=A4806FC9F70089F0&vid=&iid=B31275AF3241DB2D&sid=240CB58995465C01&eid=0A8675156EB60B87&fileno=20060619&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="37904DC365DD7266"; var my_aid="A4806FC9F70089F0";